Morgan Stanley’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17,767
| Closed | -$347K | – | 7972 |
|
|
2022
Q4 | $347K | Sell |
17,767
-139,429
| -89% | -$2.72M | ﹤0.01% | 5420 |
|
|
2022
Q3 | $3.22M | Buy |
157,196
+48,867
| +45% | +$1M | ﹤0.01% | 4045 |
|
|
2022
Q2 | $3.47M | Buy |
108,329
+105,746
| +4,094% | +$3.38M | ﹤0.01% | 4089 |
|
|
2022
Q1 | $106K | Sell |
2,583
-24,834
| -91% | -$1.02M | ﹤0.01% | 6270 |
|
|
2021
Q4 | $1.22M | Buy |
27,417
+21,202
| +341% | +$940K | ﹤0.01% | 4936 |
|
|
2021
Q3 | $309K | Buy |
6,215
+628
| +11% | +$31.2K | ﹤0.01% | 5768 |
|
|
2021
Q2 | $297K | Buy |
5,587
+654
| +13% | +$34.8K | ﹤0.01% | 5815 |
|
|
2021
Q1 | $228K | Sell |
4,933
-37,855
| -88% | -$1.75M | ﹤0.01% | 5587 |
|
|
2020
Q4 | $2.04M | Buy |
42,788
+38,098
| +812% | +$1.82M | ﹤0.01% | 4141 |
|
|
2020
Q3 | $208K | Sell |
4,690
-546
| -10% | -$24.2K | ﹤0.01% | 5093 |
|
|
2020
Q2 | $197K | Buy |
5,236
+1,458
| +39% | +$54.9K | ﹤0.01% | 5085 |
|
|
2020
Q1 | $159K | Buy |
+3,778
| New | +$159K | ﹤0.01% | 4968 |
|